Notwithstanding the need to explore in more detail as to which cancers and genetic subtypes gain advantage from this mechanism, it will be interesting to explore whether other mRNAs associated with different metabolic pathways are also targeted by SESN2. This evidence concerns the gene SESN2 and cancer.